Skip to Content

125SLXP (Mytesi crofelemer delayed-release 125 mg)

Generic Name: crofelemer

Pill with imprint 125SLXP is White, Elliptical / Oval and has been identified as Mytesi crofelemer delayed-release 125 mg. It is supplied by Napo Pharmaceuticals, Inc..

Mytesi is used in the treatment of diarrhea and belongs to the drug class antidiarrheals. Risk cannot be ruled out during pregnancy. Mytesi crofelemer delayed-release 125 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 125SLXP

Mytesi

Generic Name:
crofelemer
Imprint:
125SLXP
Strength:
crofelemer delayed-release 125 mg
Color:
White
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Antidiarrheals
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Napo Pharmaceuticals, Inc.
National Drug Code (NDC):
70564-0802

Get help with Imprint Code FAQs.

More about Mytesi (crofelemer)

Consumer resources

Other brands: Fulyzaq

Professional resources

Related treatment guides

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide